Most Read Articles
Jairia Dela Cruz, 18 Dec 2018
The use of ixekizumab to selectively target interleukin-17A (IL-17A) in disease-modifying antirheumatic drug-naïve patients with ankylosing spondylitis yields improvements in disease activity, health-related quality of life, day-to-day physical activity, and bone marrow oedema of the spine and sacroiliac joint, according to the results of the phase III COAST-V study.
10 Jan 2019
Only a few sonographic enthesitis scoring instruments developed for spondyloarthritis (SpA) have been validated in psoriatic arthritis (PsA), and none of them passed the Outcome Measures in Rheumatology (OMERACT) filter in patients with PsA, according to a systematic review.

Pulmonary arterial hypertension, peripheral arterial disease predict VTE in systemic sclerosis

06 Aug 2018

The risk of venous thromboembolism (VTE) in systemic sclerosis (SSc) is similar to that in the general population, according to a recent study. Risk factors for VTE include the presence of pulmonary arterial hypertension (PAH), peripheral arterial disease (PAD), Scl-70 and anticardiolipin antibodies.

In addition, VTE is not an independent predictor of SSc survival.

A total of 1,181 patients with SSs were included, of which 40 (3.4 percent) had VTE events. There was a 2.7 (95 percent CI, 1.9–3.7) cumulative incidence of VTE per 1,000 patient-years.

VTE was predicted by the following: PAH (odds ratio [OR], 3.77; 1.83–8.17), PAD (OR, 5.31; 1.99–12.92), Scl-70 (OR, 2.45; 1.07–5.30) and anticardiolipin antibodies (OR, 5.70; 1.16–21.17). A total of 440 deaths occurred.

Furthermore, no difference in survival was observed between patients with and without VTE (hazard ratio [HR], 1.16; 0.70–1.91). Interstitial lung disease (HR, 1.54; 1.27–1.88) and PAH (HR, 1.35; 1.10–1.65) predicted mortality.

To examine the prevalence, risk factors and effect of VTE on SSc survival, the investigators conducted a cohort study of patients with SSc who fulfilled the American College of Rheumatology/European League Against Rheumatism classification criteria between 1970 and 2017.

Deep vein thrombosis referred to the thrombus on extremity ultrasound, while pulmonary embolism referred to the thrombus on thorax computed tomography angiogram. Finally, the investigators assessed the risk factors for VTE as well as time to all-cause mortality.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 18 Dec 2018
The use of ixekizumab to selectively target interleukin-17A (IL-17A) in disease-modifying antirheumatic drug-naïve patients with ankylosing spondylitis yields improvements in disease activity, health-related quality of life, day-to-day physical activity, and bone marrow oedema of the spine and sacroiliac joint, according to the results of the phase III COAST-V study.
10 Jan 2019
Only a few sonographic enthesitis scoring instruments developed for spondyloarthritis (SpA) have been validated in psoriatic arthritis (PsA), and none of them passed the Outcome Measures in Rheumatology (OMERACT) filter in patients with PsA, according to a systematic review.